Bing

The Stifel price target for the stock is $12, and the Thomson/First Call consensus ... The Stifel report indicates that Roche and Genentech are ready to initiate what is called combination studies of NewLink’s IDO/ITO inhibitor. Combination studies ...
24/7 Wall ST · 4/6/2015
Over the last year, the stock is down about 75 percent because the ... of cobimetinab and vemurafenib for metastatic melanoma with Genentech, a member of Roche (OTC: RHHBY). Exelixis CEO Michael Morrissey recently stated: “With target enrollment …
Benzinga · 2/6/2015
Regeneron Pharmaceuticals' top-selling eye drug, Eylea, bested Roche's Lucentis and Avastin in a U.S.-sponsored study in diabetes-related vision loss—though the results ... sent Regeneron's stock oscillating. The study, called Comparison of AMD …
CNBC · 2/18/2015
Genentech’s secret, anybody will tell you ... Notably, Pearson’s compensation is very closely tied to his performance, plus he bought $5M of Valeant stock when he joined in 2008. Collectively, this represents a skin-in the-game arrangement that ...
Forbes · ByDavid Shaywitz · 5/25/2013
23andMe just ... s Class B common stock. Prior to Google’s investment in 23andMe, Sergey provided approximately $2.6 million in interim debt financing to 23andMe, which was repaid as part of this financing transaction. Genentech’s Chief Executive ...
ZDNet · ByLarry Dignan · 5/22/2007
We note that the company has an agreement with Genentech, a subsidiary of Roche ... Exelixis is a Zacks Rank #2 (Buy) stock. Other favorably-placed stocks in the health care sector include Cambrex Corp. (CBM - Snapshot Report), sporting a Zacks …
ZACKS · 4/10/2015
David Ebersman did well as CFO of Genentech, regularly making more than $4 million per ... Ebersman will have made more than $100 million in salary, bonus, and stock awards. Coding whizzes may be the rockstars of the tech world, but accountants are …
Quartz · 5/1/2014
“The landscape of the biotechnology sector has experienced dramatic shifts since the IPOs of Cetus and Genentech in the early 1980s ... which not only helps diminish single-stock risk, but also helps lever the funds to positive FDA and mergers ...
ETF Trends Setting The Pace · 12/17/2014
“They look at Warren as a hero and Berkshire as a template,” said Steve Wallman, a Middleton, Wisconsin-based money manager who has invested in Berkshire since 1982 and bought stock ... Google purchased for $3.2 billion in 2014; and former …
biznews.com · 8/11/2015
Earlier in his career, Goeddel was the first scientist hired by Genentech. Peloton’s board of directors ... At the time of the deal with Amgen, McKnight’s remaining Tularik stock — less than 1 percent of the shares outstanding — converted into ...
Dallas News · ByGary Jacobson · 10/29/2011